GTCbio

Malcolm Moos, Medical Officer of Division of Cellular and Gene Therapies at FDA to give Featured Presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MAMalcolm Moos, Medical Officer of the Division of Cellular and Gene Therapies at the Food and Drug Administration (FDA) will give the featured presentation at the 4th International Stem Cell...

Jan Paul Medema, Professor of Experimental Oncology and Radiobiology at the Academic Medical Center of the University of Amsterdam, will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr. Medema will discuss colon cancer stem cells, their resistance and differentiation. A novel paradigm in tumor biology suggests that cancer...

Mark Thiede of Pfizer will give a presentation entitled “Inference by Interference: Controlling MSC Differentiation with RNAi” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr. Thiede will discuss how human adult stem cells such as bone marrow-derived mesenchymal stem cells (MSCs), the primary source of progenitors for tissue maintenance, can...

Samuel H. Wood, CEO at Stemagen, which announced on January 17, 2008 that it has become the first in the world to create, and meticulously document, a cloned human embryo using somatic cell nuclear transfer (SCNT), will give a featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr. Wood will discuss the scientific, ethical, and...

GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas and examining the current advancements and where we’re headed in the coming years. The M3D...

Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Berta will present on the power of physiologically relevant biological assays translating from early drug discovery to the clinic. Her...

Dr. Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation will give the Featured Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Caldwell will discuss broad functional profiling of molecular libraries against biological space. Over the past...

Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.” High throughput screening (HTS) is a...

FOR IMMEDIATE RELEASE December 20, 2008 Joint Presentation from Boehringer Ingelheim and Biota at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA) MONROVIA, CA – James Chafouleas, Director of Global Licensing – Virology at Boehringer Ingelheim and Leigh Farrell, Vice President of Business Development at Biota will give a joint presentation...

FOR IMMEDIATE RELEASE December 26, 2007 University of Massachusetts to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes”...